Skip to main content
ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
87,400
+5,800 (7.11%)
Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Bio-Protein Recombinant Medicines
33.40B
Log In
Log In
Log In
Log In
Upgrade
Bio-Protein Recombinant Medicines Growth
-49.04%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
33.10B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-47.91%
Log In
Log In
Log In
Log In
Upgrade
South Korea
300.00M
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-84.97%
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade